Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus – distinct roles of BAFF and APRIL

Rituximab associated late-onset neutropenia—a rheumatology case series and review of the literature

(2016) William E. Monaco et al.   CLINICAL RHEUMATOLOGY

Late-onset neutropenia after rituximab in ANCA-associated vasculitis

(2016) A Knight et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Late-onset neutropenia following rituximab treatment for rheumatologic conditions

(2014) Gabriel S. Breuer et al.   CLINICAL RHEUMATOLOGY

Late-onset Neutropenia in Patients with Rheumatoid Arthritis after Treatment with Rituximab

(2014) R. Abdulkader et al.   JOURNAL OF RHEUMATOLOGY

Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes

(2014) Patricia López et al.   RHEUMATOLOGY

Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response

(2013) T. Jonsdottir et al.   RHEUMATOLOGY

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

(2012) George K Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

(2012) Bevra H. Hahn et al.   ARTHRITIS CARE & RESEARCH

Late-onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections

(2011) Daniel Tesfa et al.   ARTHRITIS AND RHEUMATISM

Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow

(2011) T. Matthes et al.   BLOOD

Neutropenia after rituximab treatment

(2011) Ofir Wolach et al.   CURRENT OPINION IN HEMATOLOGY

Current and novel therapeutics in the treatment of systemic lupus erythematosus

(2011) Cagri Yildirim-Toruner et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

B Cell and BAFF Dependence of IFN- -Exaggerated Disease in Systemic Lupus Erythematosus-Prone NZM 2328 Mice

(2011) N. Jacob et al.   JOURNAL OF IMMUNOLOGY

Dissecting the Immune Cell Mayhem That Drives Lupus Pathogenesis

(2011) J. E. Craft   Science Translational Medicine

Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus

(2011) R. Lande et al.   Science Translational Medicine

Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms

(2011) Daniel Tesfa et al.   Expert Review of Hematology

Neutropenia associated with rituximab therapy

(2010) Cliona Grant et al.   CURRENT OPINION IN HEMATOLOGY

Late-Onset Neutropenia After Rituximab Treatment

(2010) Ofir Wolach et al.   MEDICINE

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study

(2009) John N. Boletis et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis

(2008) Daniel Tesfa et al.   MEDICAL ONCOLOGY